{"component": "definition", "props": {"groups": [{"samples": [{"hash": "5D5QMzbEHUL", "uri": "/contracts/5D5QMzbEHUL#field", "label": "Assignment Agreement (Semnur Pharmaceuticals, Inc.)", "score": 36.3018493652, "published": true}, {"hash": "64eggMp03C1", "uri": "/contracts/64eggMp03C1#field", "label": "Collaboration and License Agreement (Xencor Inc)", "score": 36.1567420959, "published": true}, {"hash": "23JjVsovUa2", "uri": "/contracts/23JjVsovUa2#field", "label": "Assignment and Assumption of License (IMAC Holdings, Inc.)", "score": 36.1184120178, "published": true}], "snippet": "means all fields of use.", "snippet_links": [{"key": "fields-of-use", "type": "clause", "offset": [10, 23]}], "size": 350, "hash": "a70287519b23470eb76802c98eaa76ef", "id": 1}, {"samples": [{"hash": "62UigPmAr3u", "uri": "/contracts/62UigPmAr3u#field", "label": "License Agreement (Alto Neuroscience, Inc.)", "score": 34.9876785278, "published": true}, {"hash": "b1GlbQJi6gp", "uri": "/contracts/b1GlbQJi6gp#field", "label": "License Agreement (CytomX Therapeutics, Inc.)", "score": 29.8459949493, "published": true}, {"hash": "1LAjMh1b9DU", "uri": "/contracts/1LAjMh1b9DU#field", "label": "Development and License Agreement (Immunogen Inc)", "score": 29.3504447937, "published": true}], "snippet": "means all human therapeutic, prophylactic and diagnostic uses.", "snippet_links": [], "size": 218, "hash": "35eb00a3f88125cc00f084194d6f71d1", "id": 2}, {"samples": [{"hash": "SLmDn4SlJV", "uri": "/contracts/SLmDn4SlJV#field", "label": "License Agreement (Avalyn Pharma Inc.)", "score": 37.2655715942, "published": true}, {"hash": "kMpYDcBmwM7", "uri": "/contracts/kMpYDcBmwM7#field", "label": "License Agreement (Avalyn Pharma Inc.)", "score": 37.2080764771, "published": true}, {"hash": "dHyGyJ7J1su", "uri": "/contracts/dHyGyJ7J1su#field", "label": "License Agreement (Avalyn Pharma Inc.)", "score": 37.0985641479, "published": true}], "snippet": "means [***].", "snippet_links": [], "size": 188, "hash": "42145ccc68badf480a8ed917c57dd5fc", "id": 3}, {"samples": [{"hash": "h63OUtllcNo", "uri": "/contracts/h63OUtllcNo#field", "label": "Manufacturing License and Technology Transfer Agreement (Applied Genetic Technologies Corp)", "score": 29.6926765442, "published": true}, {"hash": "6mr9CLDLMyA", "uri": "/contracts/6mr9CLDLMyA#field", "label": "Collaboration and License Agreement (Applied Genetic Technologies Corp)", "score": 29.6926765442, "published": true}, {"hash": "bK0vxHAxHi0", "uri": "/contracts/bK0vxHAxHi0#field", "label": "Collaboration and License Agreement (Applied Genetic Technologies Corp)", "score": 26.6892547607, "published": true}], "snippet": "means the diagnosis, treatment or prevention of disease in humans or animals in any and all indications.", "snippet_links": [], "size": 168, "hash": "68f2ae10cf63ee92b9f200194e87be0e", "id": 4}, {"samples": [{"hash": "huyHfHrQVLH", "uri": "/contracts/huyHfHrQVLH#field", "label": "Licensing Agreement", "score": 30.3408622742, "published": true}, {"hash": "fHBxzfa5RwB", "uri": "/contracts/fHBxzfa5RwB#field", "label": "Licensing Agreement (Tg Therapeutics, Inc.)", "score": 25.0513343811, "published": true}, {"hash": "dfNA0Azzrau", "uri": "/contracts/dfNA0Azzrau#field", "label": "Licensing Agreement (Tg Therapeutics, Inc.)", "score": 24.867898941, "published": true}], "snippet": "means the prevention, treatment or amelioration of any disease or condition in humans.", "snippet_links": [], "size": 160, "hash": "577aab0750c33fe21a5b1cee18e9a2b8", "id": 5}, {"samples": [{"hash": "7wSU09vhieX", "uri": "/contracts/7wSU09vhieX#field", "label": "Collaboration and License Agreement (Amgen Inc)", "score": 35.1190948486, "published": true}, {"hash": "Dd3kqpGxIO", "uri": "/contracts/Dd3kqpGxIO#field", "label": "Nanotherapeutics License Agreement (XOMA Corp)", "score": 33.8377838135, "published": true}, {"hash": "1yqS61reXHz", "uri": "/contracts/1yqS61reXHz#field", "label": "License and Collaboration Agreement (Sutro Biopharma, Inc.)", "score": 33.5995903015, "published": true}], "snippet": "means [*].", "snippet_links": [], "size": 125, "hash": "ac6a3a2bc7031c3b669fcc02a1bd946a", "id": 6}, {"samples": [{"hash": "2Y2ghIveISr", "uri": "/contracts/2Y2ghIveISr#field", "label": "License Agreement (Jounce Therapeutics, Inc.)", "score": 30.8480491638, "published": true}, {"hash": "eVV8nonaNvJ", "uri": "/contracts/eVV8nonaNvJ#field", "label": "Option and License Agreement (Agenus Inc)", "score": 30.2073917389, "published": true}, {"hash": "32pDZuR3QbP", "uri": "/contracts/32pDZuR3QbP#field", "label": "License Agreement (Agenus Inc)", "score": 30.2073917389, "published": true}], "snippet": "means any and all uses or purposes, including the treatment, prophylaxis, palliation, diagnosis, or prevention of any human or animal disease, disorder, or condition.", "snippet_links": [], "size": 110, "hash": "12e789add24a3cc416af119aad8e47d1", "id": 7}, {"samples": [{"hash": "4fBWihDWElc", "uri": "/contracts/4fBWihDWElc#field", "label": "Exclusive Research Collaboration, Option and License Agreement (Silence Therapeutics PLC)", "score": 34.1991767883, "published": true}, {"hash": "aY3sTZMe74S", "uri": "/contracts/aY3sTZMe74S#field", "label": "License Agreement (XOMA Corp)", "score": 34.1827507019, "published": true}, {"hash": "kWk1ab86y5e", "uri": "/contracts/kWk1ab86y5e#field", "label": "Exclusive Research Collaboration, Option and License Agreement (Silence Therapeutics PLC)", "score": 33.2053375244, "published": true}], "snippet": "means all therapeutic, prophylactic, palliative and diagnostic uses in humans and animals.", "snippet_links": [], "size": 104, "hash": "a3f2592569dbb4f42391bc881c198d42", "id": 8}, {"samples": [{"hash": "es4k1N2hczW", "uri": "https://ogcc.idaho.gov/wp-content/uploads/Utah_AdminRule_R649_combined.pdf", "label": "ogcc.idaho.gov", "score": 18.8227672577, "published": false}, {"hash": "21B8xTHiWyc", "uri": "https://ogm.utah.gov/wp-content/uploads/2025/03/R649-1-2-3-8-Changes.pdf", "label": "ogm.utah.gov", "score": 18.2222995758, "published": false}, {"hash": "8rKVXnUzgI7", "uri": "https://search-prod.lis.state.oh.us/api/v2/general_assembly_135/legislation/sb342/00_IN/pdf/", "label": "search-prod.lis.state.oh.us", "score": 17.715549469, "published": false}], "snippet": "means the general area underlaid by one or more pools.", "snippet_links": [{"key": "general-area", "type": "definition", "offset": [10, 22]}], "size": 87, "hash": "926d4c4edfa2087153b1f095ff2e2cfd", "id": 9}, {"samples": [{"hash": "iDSwaWusopv", "uri": "https://stormresourcesltd.com/wp-content/uploads/2020/04/AIF-FINAL-Mar.30.pdf", "label": "stormresourcesltd.com", "score": 10.1211500168, "published": false}, {"hash": "3YPxXh76iGV", "uri": "https://www.stormresourcesltd.com/wp-content/uploads/2017/09/AIF-FINAL-Mar-11.pdf", "label": "Note", "score": 9.6214923859, "published": false}, {"hash": "eEdMTzYZk5B", "uri": "https://www.stormresourcesltd.com/wp-content/uploads/2019/03/AIF-Mar.29-19-FINAL.pdf", "label": "www.stormresourcesltd.com", "score": 9.6187543869, "published": false}], "snippet": "means an area consisting of a single reservoir or multiple reservoirs all grouped on or related to the same individual geological structural feature and/or stratigraphic condition. There may be two or more reservoirs in a field that are separated vertically by intervening impervious strata or laterally by local geologic barriers, or both. Reservoirs that are associated by being in overlapping or adjacent fields may be treated as a single or common operational field. The geological terms \u201cstructural feature\u201d and \u201cstratigraphic condition\u201d are intended to denote localized geological features, in contrast to broader terms such as \u201cbasin\u201d, \u201ctrend\u201d, \u201cprovince\u201d, \u201cplay\u201d or \u201carea of interest\u201d.", "snippet_links": [{"key": "related-to", "type": "clause", "offset": [88, 98]}, {"key": "impervious-strata", "type": "definition", "offset": [273, 290]}, {"key": "area-of-interest", "type": "clause", "offset": [675, 691]}], "size": 78, "hash": "522a9f30df8f6fbd6a522b61a100486d", "id": 10}], "next_curs": "ClISTGoVc35sYXdpbnNpZGVyY29udHJhY3Rzci4LEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiIOZmllbGQjMDAwMDAwMGEMogECZW4YACAA", "definition": {"title": "Field", "snippet": "means all fields of use.", "size": 12092, "id": "field", "examples": ["Within one hundred eighty (180) days following the Effective Date, NVP shall prepare and provide to the Advisory Committee a draft Development Plan for development of Licensed Product in the <strong>Field</strong> in the Territory for the subsequent twelve (12)-month period, and shall consider in good faith all reasonable comments provided by \u2587\u2587\u2587\u2587\u2587\u2587\u2587 and the Advisory Committee before preparing a final version of such plan for review by the Advisory Committee.", "NVP shall conduct all Development of the Licensed Compound and Licensed Product in the <strong>Field</strong> in the Territory in accordance with the then-current Development Plan and in compliance with all applicable laws.", "YUNGJIN shall be solely responsible for, at its sole expense, development of the Licensed Compound and Licensed Product in the <strong>Field</strong> in the Retained Territory.", "The regulatory interactions may include seeking scientific advice and applications for Orphan Drug Designation (\u201cODD\u201d) in the EU and the US for the treatment of mitochondrial disorders within the <strong>Field</strong>."], "related": [["commercialization", "Commercialization", "Commercialization"], ["licensed-territory", "Licensed Territory", "Licensed Territory"], ["licensed-products", "Licensed Products", "Licensed Products"], ["field-of-use", "Field of Use", "<strong>Field</strong> of Use"], ["licensed-field", "Licensed Field", "Licensed <strong>Field</strong>"]], "related_snippets": [], "updated": "2026-04-19T04:24:51+00:00"}, "json": true, "cursor": ""}}